Our data show that the serum concentrations of anti-tuberculosis drugs varied considerably in the study patients. Therapeutic drug monitoring is necessary to identify patients with subtherapeutic INH and RMP serum concentrations.
No takes yet. Share an insight, caveat, or question.
Babalık et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: